Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 1/20 | 0.58 |
| ▸ | APP | P05067 | 2/20 | 0.56 |
| ▸ | TYR | P14679 | 2/20 | 0.55 |
| ▸ | SLC28A3 | Q9HAS3 | 3/20 | 0.55 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.54 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.54 |
| ▸ | ACHE | P22303 | 1/20 | 0.54 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.53 |
| ▸ | DPP4 | P27487 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4635920 | 0.91 | SLC28A3 (0.58) | SNCAAPPTYRSLC28A3AKR1B1 | |
| SCHEMBL4636842 | 0.88 | TYR (0.53) | SNCATYRSLC28A3SLC5A1SLC5A2 | |
| SCHEMBL31131425 | 0.88 | SLC28A3 (0.63) | SNCATYRSLC28A3SLC5A1SLC5A2 | |
| SCHEMBL7780290 | 0.87 | TYR (0.52) | SNCATYRSLC28A3SLC5A1SLC5A2 | |
| SCHEMBL4635939 | 0.87 | AKR1B1 (0.53) | SNCATYRSLC28A3SLC5A1SLC5A2 | |
| SCHEMBL5435886 | 0.87 | SNCA (0.57) | SNCAAPPSLC28A3ACHEPTGS1 | |
| SCHEMBL5428987 | 0.87 | SNCA (0.57) | SNCAAPPSLC28A3ACHEPTGS1 | |
| SCHEMBL5431937 | 0.87 | SNCA (0.57) | SNCAAPPSLC28A3ACHEPTGS1 | |
| SCHEMBL4636845 | 0.86 | TYR (0.59) | TYRSLC28A3SLC5A1SLC5A2ACHE | |
| SCHEMBL4635907 | 0.86 | SLC28A3 (0.54) | SNCATYRSLC28A3SLC5A1SLC5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140023602-A1 | EXTERNAL PREPARATION FOR SKIN CONTAINING A PHOSPHORYLATED SACCHARIDE | EZAKI GLICO CO., LTD. (JP) | 2014-01-23 | — | — | US | disclosed |
| US-20080274068-A1 | External Preparation for Skin Containing a Phosphorlated Saccharide | EZAKI GLICO CO., LTD. (JP) | 2008-11-06 | — | — | US | disclosed |
| EP-1932514-A1 | PHARMACEUTICAL PREPARATION FOR EXTERNAL APPLICATION TO SKIN COMPRISING PHOSPHORYLATED SUGAR | Ezaki Glico Co., Ltd. (JP) | 2008-06-18 | — | — | EP | disclosed |
| EP-0649648-B1 | Skin whitening agents containing glycosides | SHISEIDO CO LTD (JP) | 2001-09-19 | — | — | EP | disclosed |
| EP-0649648-A2 | Skin whitening agents containing glycosides | SHISEIDO COMPANY LIMITED (JP) | 1995-04-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140023602-A1 | EXTERNAL PREPARATION FOR SKIN CONTAINING A PHOSPHORYLATED SACCHARIDE | SI, CUTA, CD44 | SNCA 4021/4885APP 2909/4885TYR 149/4885 |
| US-20080274068-A1 | External Preparation for Skin Containing a Phosphorlated Saccharide | CUTA, SI, CD44 | SNCA 4076/4885APP 2605/4885TYR 113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.